Primary Carcinoma of the Fallopian Tube
article
OA: closed
CC0
⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper discusses primary carcinoma of the Fallopian tube, a rare gynecological malignancy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (26)
- A Report of Three Cases of Primary Cancer of the Fallopian Tubes via openalex
- Primary Cancer of the Fallopian Tube via openalex
- Primary carcinoma of the fallopian tubes via openalex
- Primary carcinoma of the fallopian tube, with a report of two cases via openalex
- The Early Diagnosis of Adnexal Cancer via openalex
- W2009171263 via openalex
- W2021832917 via openalex
- W2073141582 via openalex
- W2110006662 via openalex
- W2169334942 via openalex
- W2251788132 via openalex
- W2330072595 via openalex
- W2333221034 via openalex
- W2424976218 via openalex
- W2564849094 via openalex
- W2787829313 via openalex
- W4206720905 via openalex
- W4247705448 via openalex
- W4250870281 via openalex
- W4251967611 via openalex
- W1546727134 via openalex
- W4301951621 via openalex
- W1624117926 via openalex
- W1624121975 via openalex
- W1976924247 via openalex
- W2006662472 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK